 storage secretion sensitivity specificity diagnosis pheochromocytoma co-stored co-released catecholamines adrenal medullary sympathetic neuronal vesicles plasma patients pheochromocytoma usefulness hormone differential diagnosis hypertension elevated level chromogranin comparable diagnostic sensitivity diagnostic specificity level plasma catecholamines subjects pheochromocytoma comparison several reference groups normotensive controls essential hypertension renovascular hypertension subjects primary aldosteronism Subjects signs symptoms pheochromocytoma diagnosis normal plasma levels chromogranin modest rise chromogranin essential hypertension correlation chromogranin diastolic blood pressure normotensive patients patients essential hypertension diagnostic usefulness chromogranin pheochromocytoma Renal failure elevated plasma chromogranin blood pressure Plasma tumor mass tumor content tumor norepinephrine content urinary vanillylmandelic acid excretion plasma urinary catecholamines blood pressure patients pheochromocytoma Plasma levels subjects pheochromocytoma age sex tumor location tumor pathology Several drugs diagnosis treatment pheochromocytoma clonidine metoprolol phentolamine tyramine little effect plasma chromogranin concentration pheochromocytoma catecholamines soluble core chromaffin granules vesicle soluble protein chromogranin emerges catecholamines pheochromocytoma chromaffin granules plasma chromogranin sensitive specific diagnostic tool evaluation actual suspected pheochromocytoma plasma chromogranin pheochromocytoma tumor size overall catecholamine production drugs diagnosis treatment pheochromocytoma little effect plasma chromogranin level usefulness chromogranin pheochromocytoma measurement chromogranin useful adjunct diagnosis pheochromocytoma